Research Triangle Park, N.C.-based CATO SMS and Bracknell, U.K.-headquartered Pharm-Olam, both providers of specialized clinical research services, announced today that they are merging to form a leading global biopharmaceutical services organization uniquely positioned to serve the growing number of small and mid-sized companies developing complex therapies.
Although smaller businesses currently account for nearly 70% of the biopharmaceutical industry’s intellectual property, they have often found it challenging to receive the full attention of senior resources required to effectively design and manage clinical studies. CATO SMS and Pharm-Olam are joining forces to address this gap and serve the specific needs of small and mid-sized businesses.
